SPECTROM Introduces Real-Time Medication Accountability Platform

Research has highlighted significant concerns about medication diversion in U.S. jails and prisons, prompting SPECTROM to introduce a new platform aimed at enhancing real-time accountability. The platform, called OperationalIQ™, is designed to track controlled-substance transactions, flag discrepancies in real time, and enable immediate intervention by correctional leaders.

Every day, correctional facilities across the United States administer thousands of prescription medications, including controlled substances used to treat pain, mental health conditions, and opioid use disorder. However, the complex process of moving these medications through multiple personnel, locations, and handoffs creates accountability challenges that traditional inventory counts and delayed reporting cannot fully address.

SPECTROM identified this accountability gap and developed OperationalIQ™ to address it. The platform connects medication tracking, verified staff access, time-stamped records, and management oversight into an auditable digital chain of custody. It integrates barcode-supported tracking, identity-linked transactions, medication-cart connectivity, secure cloud infrastructure, and automated exception reporting. Transactions processed through the platform create records of the activity and associated personnel, helping administrators trace medication movement from inventory through administration and reconciliation.

The critical difference with OperationalIQ™ is its ability to flag detected exceptions against configured accountability rules and make them visible in real time. Authorized wardens, healthcare administrators, and designated oversight personnel receive discrepancy information through a secure management portal. They can identify the affected transaction, direct personnel to pause the relevant medication-transfer workflow, secure the medication, investigate the issue, and authorize resumption under facility procedures.

This changes the oversight process from reviewing historical records to responding while an identified issue can still be addressed. It also creates a documented record of the exception and subsequent review, supporting internal investigations, management accountability, and compliance-related recordkeeping.

The scale of medication administration in correctional facilities is significant. A Sacramento County report documented approximately 16,327 prescription medication doses administered daily across two county jail facilities in fiscal year 2019-20; these were not exclusively controlled substances. New York State separately reported 3,195 incarcerated people receiving buprenorphine or methadone treatment across 42 state correctional facilities as of July 1, 2025. That figure represents patients, not daily doses.

A 2024 U.S. Department of Justice inspector general report identified medication-administration monitoring deficiencies at a federal prison, while published research has documented correctional healthcare staff concerns about diversion. OperationalIQ™ builds on technology SPECTROM already uses in other healthcare-related settings. The correctional program is entering pilot evaluation, where facility-specific integration, accountability performance, and operational results will be assessed.

SPECTROM's objective is zero unaccounted-for diversion: documented transactions, visible discrepancies, and investigated exceptions. This is an accountability standard, not a promise that every possible act of diversion can be prevented or detected.

For correctional administrators, the broader opportunity is a consistent view of medication accountability across personnel and locations, with transaction-level information available to support timely decisions rather than relying exclusively on retrospective reporting. SPECTROM is engaging state corrections departments, county jail administrators, correctional healthcare contractors, and pharmacy leaders interested in evaluating the technology. Pilot scope and timing will be determined collaboratively.